Today AstraZenica announced late stage trials of its COVID-19 vaccine with Oxford University Senator Steve Daines participated with in it tests could be up to 90% effective against the coronavirus. Chief Executive Officer Pascal Soriot says a possible trial of the half dose regimen could come to the U.S. before the end of the year.
Related Posts
October 24, 2025
Some Ballots Rejected For Not Writing Birth Year On Envelopes
October 23, 2025
November SNAP Benefits Stop If Federal Government Doesn’t Reopen
October 22, 2025
NorthWestern Energy Plans ‘Large Load’ Tariff For Data Centers
October 21, 2025